Organised by the NEPHOS research group, the objective is to share advances to further increase the functionality and reduce the cost of semiconductor devices, such as chips
Show all news from "School of Engineering"
Students from the United University of India have been studying artificial intelligence and students from the Western University of Canada are studying engineering, as well as going sightseeing in the region.
Experts from the URV point out that this method significantly reduces the quality of the data, refuse to accept that traditional mechanisms pose a risk to privacy and call on institutions not to follow suit
24/03/2023
The first URV Festival: a great success
Figa Flawas, JazzWoman and DJ Ceba top the bill at the Festival attended by hundreds of people
A hydroalcoholic gel with a QR code enables people to access to a test that assesses their ability to identify the smell of the product and eight symptoms of the disease. Using artificial intelligence techniques, it instantly evaluates the risk of having Covid. The first prototype of this system is being used in the Emergency Department of Hospital Sant Joan de Reus
A research group of the Universitat Rovira i Virgili, led by Professor Domènec Puig, classifies types of breast cancer and predicts the likelihood of metastasis
The URV is taking part in the SECURING project, coordinated by the UOC, which in the coming years will develop new technological solutions to guarantee the safety and sustainability of the ecosystems based on the Internet of Things
30/01/2023
ChatGPT has reached the University
The new artificial intelligence system capable of answering any question with natural language poses challenges for teaching methodology and evaluation. But the key to its good use is critical thinking, a core competence in university education.
Three are led by the CloudLab research group, coordinated by the researcher from the Department of Computer Engineering and Mathematics, Pedro García
The URV-IISPV researcher Òscar Yanes has taken part in this research, which aims to improve the response of these cancer cells to a treatment that is already used for other illnesses